Page 20 - Onsensus Estimate News Today

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -200% and 1.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Procter & Gamble's (PG) focus on productivity and cost-saving plans to boost margins, along with pricing actions bode well.

While the top- and bottom-line numbers for RH (RH) give a sense of how the business performed in the quarter ended July 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Journey Medical (DERM) enters into a second licensing agreement with Maruho to develop and commercialize Qbrexza to treat hyperhidrosis in certain Asian countries. The stock surges 18.4%.

Supply chain visibility provider Descartes leans on past acquisitions to grow through the downcycle. The post Descartes posts record results at bottom of freight cycle appeared first on FreightWaves.

CCAP and NVT made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 7, 2023.

PCAR, PUBGY and OFS made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 5, 2023.

Mastercard's (MA) strategic alliances and partnerships are major tailwinds.

BSM, GSBD and SMMF made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 31, 2023.

The acquisition will help strengthen Accenture's (ACN) digital technology and automation capabilities in West Australia.